Skip to main content

Market Overview

Navidea Biopharmaceuticals, Inc. (AMEX: NAVB)

1.55 -0.04 (-2.52%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
After-Hours
EPS:
REV:




Q4 2021
After-Hours
EPS:
REV:




Q3 2021
After-Hours
EPS:
REV:
-0.13
268.389K



Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
-0.13
156.272K
-0.08
-0.09
123.737K
-12.5%
Q4 2020
After-Hours
EPS:
REV:
-0.15
119.299K
-0.12
600K
-0.11
219.251K
8.33%
-63.46%
Q3 2020
After-Hours
EPS:
REV:
-0.17
236.811K
-0.09
150K
-0.13
268.389K
-44.44%
78.93%
Q2 2020
After-Hours
EPS:
REV:
-0.24
260.092K

156K
-0.11
271.101K

73.78%
Q1 2020
After-Hours
EPS:
REV:
-0.24
136.032K

-0.13
156.272K

Q4 2019
After-Hours
EPS:
REV:
-0.02
119.321K
-0.12
-0.15
119.299K
-25%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!